Literature DB >> 2351757

Choline acetyltransferase-immunoreactive profiles are presynaptic to primary sensory fibers in the rat superficial dorsal horn.

A Ribeiro-da-Silva1, A C Cuello.   

Abstract

The specific aim of this study was to search for morphological counterparts to the known antinociceptive effects of cholinomimetic drugs at the spinal cord level. For this, the light microscopic and ultrastructural distribution of choline acetyltransferase immunoreactivity was studied in laminae I-III of the rat cervical spinal cord. Immunoreactivity was present in cell bodies in lamina III, and in dendrites and axons of all three laminae. Immunoreactive axonal varicosities were often presynaptic to the central varicosities of type II synaptic glomeruli in lamina II and lamina III, less often presynaptic to the central elements of type I glomeruli in lamina II, and often presynaptic to dendrites in both type I and type II glomeruli. In addition, immunoreactive dendrites were often postsynaptic to the central varicosities of glomeruli of all morphological types. These results indicate that 1) primary sensory fibers excite cholinergic interneurons; 2) the acetylcholine released by the axon terminals of these interneurons modulates both nociceptive and non-nociceptive sensory information at the spinal cord level through both pre- and postsynaptic mechanisms. Furthermore, our results reinforce current ideas on reciprocal sensory interaction between thick and fine afferent fibers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351757     DOI: 10.1002/cne.902950303

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  19 in total

1.  Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat.

Authors:  Jonathan M Beckel; Lori A Birder
Journal:  J Physiol       Date:  2012-01-16       Impact factor: 5.182

Review 2.  Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia.

Authors:  Theodore J Price; Fernando Cervero; Yves de Koninck
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

3.  Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn.

Authors:  H Baba; T Kohno; M Okamoto; P A Goldstein; K Shimoji; M Yoshimura
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

Review 4.  Neurotransmitters in subcortical somatosensory pathways.

Authors:  J Broman
Journal:  Anat Embryol (Berl)       Date:  1994-03

5.  Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones.

Authors:  Sergio Fucile; Antonietta Sucapane; Fabrizio Eusebi
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

6.  Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats.

Authors:  De-Pei Li; Shao-Rui Chen; Yu-Zhen Pan; Allan I Levey; Hui-Lin Pan
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

7.  The effects of cholinoceptor agonists and antagonists on C-fibre evoked responses in the substantia gelatinosa of neonatal rat spinal cord slices.

Authors:  L Bleazard; R Morris
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Transdermal nitroglycerine enhances postoperative analgesia of intrathecal neostigmine following abdominal hysterectomies.

Authors:  Fareed Ahmed; Ashish Garg; Vipul Chawla; Mamta Khandelwal
Journal:  Indian J Anaesth       Date:  2010-01

9.  Muscarinic excitatory and inhibitory mechanisms involved in afferent fibre-evoked depolarization of motoneurones in the neonatal rat spinal cord.

Authors:  T Kurihara; H Suzuki; M Yanagisawa; K Yoshioka
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

10.  Short- and long-term enhancement of excitatory transmission in the spinal cord dorsal horn by nicotinic acetylcholine receptors.

Authors:  Jonathan R Genzen; Daniel S McGehee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.